---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-015239"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2026-02-12T23:59:59+00:00"
generated_at: "2026-05-16T03:07:05.900837+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals regains Nasdaq compliance on minimum bid price; delisting hearing cancelled

## Summary
- Received Nasdaq notice on Feb 11 confirming compliance with minimum bid price rule 5550(a)(2).
- Prior delisting notice from Jan 20, 2026 was appealed and stayed pending hearing.
- Hearing scheduled for Feb 19, 2026 has been cancelled; matter closed.
- Company's common stock and warrants continue trading on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-26-015239
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2026-02-12T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390026015239/0001213900-26-015239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390026015239/ea0276747-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-015239
- JSON: https://secwatch.observer/filing/0001213900-26-015239.json
- Plain text: https://secwatch.observer/filing/0001213900-26-015239.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.